{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:41:56Z","timestamp":1774330916627,"version":"3.50.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Prostate-Specific Membrane Antigen (PSMA) is a highly expressed and structurally unique target specific to prostate cancer (PCa). Diagnostic and therapeutic approaches in nuclear medicine, coupling PSMA ligands with radionuclides, have shown significant clinical success. PSMA-PET\/CT effectively identifies tumors and metastatic lymph nodes for imaging purposes, while <jats:sup>177Lu<\/jats:sup>-PSMA-617 (Pluvicto) has received FDA approval for treating metastatic castration-resistant PCa (mCRPC). Despite their success, radionuclide-based diagnostic and therapeutic methods face limitations such as high costs and significant side effects. Recently, near-infrared (NIR) fluorescence imaging and phototherapy have advanced significantly in biomedical applications. It\u2019s benefits, such as deep tissue penetration, real-time precision, and minimal side effects, have driven broader clinical adoption, especially in fluorescence-guided surgery (FGS). This review suggests combining NIR dyes with PSMA ligands to enable targeted, high-resolution imaging with superior signal-to-background ratios, facilitating precise FGS. NIR techniques can also aid pathological diagnosis in ex vivo specimens. Furthermore, combining photosensitizers with PSMA ligands allows localized photothermal (PTT) or photodynamic therapy (PDT) under NIR irradiation, producing heat or reactive oxygen species (ROS) to treat PCa. This review aims to extend the clinical success of radionuclide-based PSMA targeting by exploring advances in NIR-based FGS and phototherapy, presenting a promising new diagnostic and therapeutic approach.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1533532","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:13:54Z","timestamp":1736489634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Advances in prostate-specific membrane antigen-targeted theranostics: from radionuclides to near-infrared fluorescence technology"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhongji","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaohaer","family":"Kadeerhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112152-20220922-00647","article-title":"Cancer statistics in China, 2016","volume":"45","author":"Zheng","year":"2023","journal-title":"Zhonghua zhong liu za zhi [Chinese J Oncol]"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2146","article-title":"Stimulated Raman scattering microscopy enables gleason scoring of prostate core needle biopsy by a convolutional neural network","volume":"83","author":"Ao","year":"2023","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2440591","DOI":"10.1001\/jamanetworkopen.2024.40591","article-title":"Long-term outcomes of prostate-specific membrane antigen-PET imaging of recurrent prostate cancer","volume":"7","author":"Kunst","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2022.12.001","article-title":"Prostate-specific membrane antigen-radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases","volume":"6","author":"Lunger","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7150\/thno.95039","article-title":"Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection","volume":"14","author":"Jiao","year":"2024","journal-title":"Theranostics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.v12.16","article-title":"The role of cytoreductive radical prostatectomy and lymph node dissection in bone-metastatic prostate cancer: A population-based study","volume":"8","author":"Zhai","year":"2023","journal-title":"Cancer Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002498","article-title":"Robot-assisted radical prostatectomy using the KangDuo surgical Robot-01 system: A prospective, single-center, single-arm clinical study","volume":"208","author":"Fan","year":"2022","journal-title":"J Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S2468-1253(22)00248-5","article-title":"Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial","volume":"7","author":"Feng","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s44222-022-00017-1","article-title":"Fluorescence image-guided tumour surgery","volume":"1","author":"Wang","year":"2023","journal-title":"Nat Rev Bioeng"},{"key":"B12","doi-asserted-by":"publisher","first-page":"0010","DOI":"10.1038\/s41551-016-0010","article-title":"Near-infrared fluorophores for biomedical imaging","volume":"1","author":"Hong","year":"2017","journal-title":"Nat Biomed Eng"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0502101102","article-title":"Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase","volume":"102","author":"Davis","year":"2005","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/1874471012666190729151540","article-title":"Toward the discovery and development of PSMA targeted inhibitors for nuclear medicine applications","volume":"13","author":"Pastorino","year":"2020","journal-title":"Curr Radiopharm"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.12.066","article-title":"Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs","volume":"376","author":"Barinka","year":"2008","journal-title":"J Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00539-6","article-title":"Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer","volume":"4","author":"Bakht","year":"2023","journal-title":"Nat Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_239187","article-title":"The evolving role of prostate-specific membrane antigen-based diagnostics and therapeutics in prostate cancer","volume":"39","author":"Dorff","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book Am Soc Clin Oncol Annu Meeting"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171052","article-title":"Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors","volume":"215","author":"Kaittanis","year":"2018","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00900-z","article-title":"Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer","volume":"22","author":"Bakht","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080713","article-title":"(68)Ga]Ga-PSMA-11: the first FDA-approved (68)Ga-radiopharmaceutical for PET imaging of prostate cancer","volume":"14","author":"Hennrich","year":"2021","journal-title":"Pharm (Basel Switzerland)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ph15101292","article-title":"(177)Lu]Lu-PSMA-617 (Pluvicto(TM)): the first FDA-approved radiotherapeutical for treatment of prostate cancer","volume":"15","author":"Hennrich","year":"2022","journal-title":"Pharm (Basel Switzerland)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063036","article-title":"Prognostic and theranostic applications of positron emission tomography for a personalized approach to metastatic castration-resistant prostate cancer","volume":"22","author":"Filippi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.09.040","article-title":"PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer","volume":"375","author":"Huangfu","year":"2024","journal-title":"J Controlled Release: Off J Controlled Release Soc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eururo.2023.11.018","article-title":"Prostate-specific membrane antigen-targeted therapies for prostate cancer: towards improving therapeutic outcomes","volume":"85","author":"Corpetti","year":"2024","journal-title":"Eur Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.7150\/thno.96403","article-title":"Actinium-225 targeted alpha particle therapy for prostate cancer","volume":"14","author":"Bidkar","year":"2024","journal-title":"Theranostics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00506-0","article-title":"A step closer to the use of [(177)Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer","volume":"25","author":"Jia","year":"2024","journal-title":"Lancet Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01919-6","article-title":"(177)Lu-PSMA-617 for metastatic prostate cancer: aiming for the right spot","volume":"404","author":"Mateo","year":"2024","journal-title":"Lancet (London England)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41566-024-01391-5","article-title":"In vivo NIR-II fluorescence imaging for biology and medicine","volume":"18","author":"Wang","year":"2024","journal-title":"Nat Photonics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1900321","DOI":"10.1002\/adma.201900321","article-title":"Near-infrared-II molecular dyes for cancer imaging and surgery","volume":"31","author":"Zhu","year":"2019","journal-title":"Adv Mater (Deerfield Beach Fla.)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-023-01083-5","article-title":"Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses","volume":"8","author":"Ren","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2009.294","article-title":"A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice","volume":"4","author":"Welsher","year":"2009","journal-title":"Nat Nanotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4206","DOI":"10.1038\/ncomms5206","article-title":"Ultrafast fluorescence imaging in vivo with conjugated polymer fluorophores in the second near-infrared window","volume":"5","author":"Hong","year":"2014","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nphoton.2014.166","article-title":"Through-skull fluorescence imaging of the brain in a new near-infrared window","volume":"8","author":"Hong","year":"2014","journal-title":"Nat Photonics"},{"key":"B35","article-title":"Indocyanine green: physical and physiologic properties","volume":"35","author":"Fox","year":"1960","journal-title":"Proc Staff Meetings Mayo Clin"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02126-0","article-title":"Intraoperative ICG-fluorescence imaging for robotic-assisted urologic surgery: current status and review of literature","volume":"51","author":"Pathak","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-019-0494-0","article-title":"First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I\/II windows","volume":"4","author":"Hu","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020494","article-title":"Indocyanine green fluorescence guided surgery in colorectal surgery","volume":"12","author":"Garoufalia","year":"2023","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.c.7565469","article-title":"CD24-targeted NIR-II fluorescence imaging enables early detection of colorectal neoplasia","volume":"84","author":"Guo","year":"2024","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06714-w","article-title":"Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging","volume":"51","author":"Tian","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e2310167","DOI":"10.1002\/advs.202310167","article-title":"Intraoperative Resection Guidance and Rapid Pathological Diagnosis of Osteosarcoma using B7H3 Targeted Probe under NIR-II Fluorescence Imaging","volume":"11","author":"Zeng","year":"2024","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.7150\/thno.91554","article-title":"Lower-grade gliomas surgery guided by GRPR-targeting PET\/NIR dual-modality image probe: a prospective and single-arm clinical trial","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00259-022-05975-7","article-title":"New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue","volume":"50","author":"Li","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nmat4476","article-title":"A small-molecule dye for NIR-II imaging","volume":"15","author":"Antaris","year":"2016","journal-title":"Nat Mater"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201804956","article-title":"Developing a bright NIR-II fluorophore with fast renal excretion and its application in molecular imaging of immune checkpoint PD-L1","volume":"28","author":"Wan","year":"2018","journal-title":"Adv Funct Mater"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0262-4","article-title":"In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles","volume":"37","author":"Zhong","year":"2019","journal-title":"Nat Biotechnol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-022-01130-3","article-title":"In vivo non-invasive confocal fluorescence imaging beyond 1,700\u2009nm using superconducting nanowire single-photon detectors","volume":"17","author":"Wang","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00892-0","article-title":"NIR-II light in clinical oncology: opportunities and challenges","volume":"21","author":"Zhang","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e2123111119","DOI":"10.1073\/pnas.2123111119","article-title":"High-precision tumor resection down to few-cell level guided by NIR-IIb molecular fluorescence imaging","volume":"119","author":"Wang","year":"2022","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1038\/s41467-022-33341-6","article-title":"Phosphorylcholine-conjugated gold-molecular clusters improve signal for Lymph Node NIR-II fluorescence imaging in preclinical cancer models","volume":"13","author":"Baghdasaryan","year":"2022","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00291","article-title":"A phase III study of pafolacianine injection (OTL38) for intraoperative imaging of folate receptor-positive ovarian cancer (Study 006)","volume":"41","author":"Tanyi","year":"2023","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-023-00558-4","article-title":"Prostate-specific membrane antigen (PSMA) radioguided surgery in prostate cancer: An overview of current application and future perspectives","volume":"11","author":"Muraglia","year":"2023","journal-title":"Clin Trans Imaging"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-021-01316-y","article-title":"Spatial mapping of protein composition and tissue organization: a primer for multiplexed antibody-based imaging","volume":"19","author":"Hickey","year":"2022","journal-title":"Nat Methods"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37443","article-title":"Monoclonal antibody-based molecular imaging strategies and theranostic opportunities","volume":"10","author":"Dammes","year":"2020","journal-title":"Theranostics"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0803","article-title":"Evaluation of novel prostate-specific membrane antigen-targeted near-infrared imaging agent for fluorescence-guided surgery of prostate cancer","volume":"25","author":"Kularatne","year":"2019","journal-title":"Clin Cancer Res:  Off J Am Assoc Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1021\/bc400131a","article-title":"Development of tumor-targeted near infrared probes for fluorescence guided surgery","volume":"24","author":"Kelderhouse","year":"2013","journal-title":"Bioconjugate Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00102-X","article-title":"First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial","volume":"63","author":"Stibbe","year":"2023","journal-title":"Lancet Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0821","article-title":"A prostate-specific membrane antigen-targeted near-infrared conjugate for identifying pulmonary squamous cell carcinoma during resection","volume":"21","author":"Kennedy","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.07.018","article-title":"Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection","volume":"13","author":"Wu","year":"2023","journal-title":"Acta Pharm Sinica B"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00808-8","article-title":"Intraoperative imaging in pathology-assisted surgery","volume":"6","author":"Voskuil","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"B62","doi-asserted-by":"publisher","first-page":"104476","DOI":"10.1016\/j.ebiom.2023.104476","article-title":"NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody","volume":"89","author":"Guo","year":"2023","journal-title":"EBioMedicine"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06224-1","article-title":"Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand","volume":"50","author":"Derks","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s43586-024-00301-x","article-title":"Near-infrared II fluorescence imaging","volume":"4","author":"Schmidt","year":"2024","journal-title":"Nat Rev Methods Primers"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.4c00819","article-title":"Prostate-specific membrane antigen-targeted NIR phototheranostics for prostate cancer","volume":"7","author":"Solanki","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"B67","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS nano"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-022-01189-y","article-title":"Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars","volume":"17","author":"Arami","year":"2022","journal-title":"Nat Nanotechnol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12951-024-02477-6","article-title":"A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence","volume":"22","author":"Liu","year":"2024","journal-title":"J Nanobiotechnol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1533532\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:13:57Z","timestamp":1736489637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1533532\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2024.1533532"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1533532","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1533532"}}